4//SEC Filing
Akebia Therapeutics, Inc. 4
Accession 0001562180-16-002661
$AKBACIK 0001517022operating
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:06 PM ET
Size
5.9 KB
Accession
0001562180-16-002661
Insider Transaction Report
Form 4
Dalal Anupam
Director
Transactions
- Award
Stock Option (Right to buy)
2016-06-16+12,500→ 12,500 totalExercise: $8.56From: 2017-06-16Exp: 2026-06-16→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]100% of the option shares vest on the earlier of June 16, 2017 or the date immediately prior to the next annual meeting of the Issuer after the grant date (the "Vesting Date"), provided that the Reporting Person remains in continuous service as a member of the Issuer's Board of Directors through the applicable Vesting Date, and provided further that the options held by the Reporting Person shall be eligible for vesting acceleration upon a "Change in Control" as defined and provided for in the Issuer's Non-Employee Director Stock Option Award Agreement.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001517022
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:06 PM ET
- Size
- 5.9 KB